Providing Comprehensive Solutions for Protein Therapeutics:
Over a Decade of Experience and Innovation in Protein Biomanufacturing
Protein therapeutics, including recombinant proteins, fusion proteins, enzymes, cytokines, and other biologics, are an important part of modern biopharmaceutical development. With growing demand for higher process efficiency, consistent product quality, and scalable manufacturing, developers need reliable solutions across upstream and downstream operations.
LePure Biotech supports protein biomanufacturing with integrated solutions covering cell culture, process development, filtration, purification, formulation, and filling. With more than a decade of bioprocessing experience, our portfolio includes cell culture media, single-use systems, filtration and purification solutions, and formulation and filling support.
By expanding its portfolio and strengthening process integration, LePure Biotech helps customers improve consistency, streamline operations, and scale the development and manufacture of high-quality protein therapeutics.
Protein Therapeutics Process
Upstream Process
LePure Biotech provides products and bioprocessing services for early-stage antibody and protein therapeutics development, including cell line development, media screening, and lab-scale process optimization.
Pilot Scale & Commercial Manufacturing
LePure Biotech is operates large-scale cleanroom facilities, including Class C environments with Grade A unidirectional airflow protection, as well as dedicated workshops for single-use system assembly, supporting the pilot-scale and commercial manufacturing of antibody and protein therapeutics.
LePure Biotech is supported by a global team of application and product specialists, who work closely with customers to provide technical expertise and process focused support.
Our global footprint includes manufacturing sites in Shanghai, Suzhou, and the Greater Bay Area in South China, an R&D center in Boston, USA, and a dedicated business office in Korea.
